Stockscreener 앱 받기
32.94
0.00%
0.05
전일 마감가:
$32.89
열려 있는:
$32.95
하루 거래량:
2.23M
Relative Volume:
0.52
시가총액:
$14.10B
수익:
$2.27B
순이익/손실:
$1.15B
주가수익비율:
12.92
EPS:
2.55
순현금흐름:
$2.80B
1주 성능:
+1.08%
1개월 성능:
+5.72%
6개월 성능:
+19.43%
1년 성능:
+15.77%
1일 변동 폭
$32.54
$32.98
1주일 범위
$32.08
$33.00
52주 변동 폭
$24.05
$34.20
로열티 파마 Stock (RPRX) Company Profile
명칭
Royalty Pharma Plc
전화
(212) 883-0200
주소
110 EAST 59TH STREET, NEW YORK, NY
RPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
32.94 | 14.10B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
503.20 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
608.78 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
654.64 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.62 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.96 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
로열티 파마 Stock (RPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-06-14 | 재개 | UBS | Buy |
| 2022-05-13 | 개시 | Scotiabank | Sector Outperform |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2021-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-30 | 개시 | Tigress Financial | Buy |
| 2020-11-09 | 업그레이드 | UBS | Neutral → Buy |
| 2020-07-14 | 개시 | Evercore ISI | In-line |
| 2020-07-13 | 개시 | BofA Securities | Buy |
| 2020-07-13 | 개시 | Citigroup | Neutral |
| 2020-07-13 | 개시 | Cowen | Outperform |
| 2020-07-13 | 개시 | Goldman | Neutral |
| 2020-07-13 | 개시 | JP Morgan | Neutral |
| 2020-07-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 개시 | SunTrust | Buy |
| 2020-07-13 | 개시 | UBS | Neutral |
모두보기
로열티 파마 주식(RPRX)의 최신 뉴스
387,567 Shares in Royalty Pharma plc (NASDAQ:RPRX) Acquired by AlTi Global Inc. - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) is Regal Partners Ltd's 9th Largest Position - MarketBeat
PDT Partners LLC Acquires 38,599 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Hsbc Holdings PLC Sells 30,304 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (RPRX) to Release Quarterly Earnings on Thursday - MarketBeat
MML Investors Services LLC Acquires New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by AQR Capital Management LLC - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Tudor Investment Corp ET AL - MarketBeat
First Trust Advisors LP Decreases Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Wells Fargo & Company MN Buys 15,790 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Moody’s upgrades Royalty Pharma’s rating, maintains stable outlook By Investing.com - Investing.com Nigeria
Moody’s upgrades Royalty Pharma’s rating, maintains stable outlook - Investing.com Australia
Walleye Capital LLC Buys Shares of 25,124 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Uniplan Investment Counsel Inc. Buys New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Dark Forest Capital Management LP - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Bought by GMT Capital Corp - MarketBeat
Barclays PLC Acquires 54,421 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Declares $0.22 Quarterly Dividend - MarketBeat
Brokerages Set Royalty Pharma plc (NASDAQ:RPRX) Price Target at $42.50 - MarketBeat
Cerity Partners LLC Sells 15,537 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Canada Pension Plan Investment Board Buys 39,070 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Guggenheim Capital LLC Sells 82,768 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Adage Capital Partners GP L.L.C. - MarketBeat
Raymond James Financial Inc. Buys Shares of 783,633 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Jump Financial LLC Makes New $2.09 Million Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Invesco Ltd. Raises Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Bridgewater Associates LP Acquires New Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma PLC (RPRX) Surged Following an Acquisition Announcement - Insider Monkey
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Synovus Financial Corp - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Ontario Teachers Pension Plan Board - MarketBeat
Regal Investment Advisors LLC Has $452,000 Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Evergreen Capital Management LLC Has $2.75 Million Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Declares Second Quarter 2025 Dividend - The Manila Times
Sterling Capital Management LLC Raises Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Treasurer of the State of North Carolina Sells 10,837 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Keeps Dividend at $0.22 A Share, Payable June 10 to Shareholders of Record May 16 - marketscreener.com
Royalty Pharma plc Announces Second Quarter 2025 Dividend Payment of $0.22 per Class A Ordinary Share - Nasdaq
로열티 파마 (RPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.63%
3.33%
자본화:
|
볼륨(24시간):